SINTX Technologies has completed a new 3D printing facility in Salt Lake City, Utah. The advanced ceramics and biomaterials company has now received its EXT-220 MED medical-grade 3D printers at the site.
The company develops a proprietary composite of silicon nitride and polyetheretherketone, or SiN/PEEK. Its SiNERGY™ additive manufacturing platform aims to produce orthopedic implants tailored to each patient.
From material research toward regulated production
SINTX expects its proprietary SiN/PEEK compounded filament from Evonik before the end of 2026. Meanwhile, it is working toward FDA 510(k) clearance for a defined range of patient-specific extremity implants.
The company says it could supply a limited number of eligible custom devices as early as Q1 2027. However, craniomaxillofacial (CMF) and spinal applications would follow later in 2027, depending on regulatory review.
3D Systems markets the EXT 220 MED medical extrusion 3D printer for implant-grade polymers such as PEEK. This machine previously carried the Kumovis R1 name. Following 3D Systems’ acquisition of Kumovis in 2022, the founders launched Munich Medical Devices to advance 3D printed PEEK implants.
Why add silicon nitride to PEEK?
Manufacturers already use PEEK widely for orthopedic implants, notably because it does not block X-ray imaging. SINTX proposes adding silicon nitride, a bioactive ceramic. According to laboratory studies cited by the company, this ceramic would limit bacterial adhesion and support bone growth.
One in vitro study examined 3D printed spinal cages made of SiN/PEEK. Bacterial adhesion fell by 93.9% compared with standard PEEK. However, these remain laboratory results. SINTX therefore stresses the need to assess their clinical value for each product.
The company has hired James A. Smith, Ph.D., as Director of 3D Additive-Manufacturing. He will lead process development and manufacturing validation. Smith graduated from Loughborough University in additive manufacturing and mechanical engineering. He has also published research on 3D printed PEEK cranial implants.
SINTX is also discussing AI tools with an engineering services firm. These tools would segment medical images and help design implants for each patient.
“We are bringing together years of proprietary biomaterials research, differentiated intellectual property, advanced additive manufacturing, and personalized surgical technologies to establish an integrated commercial platform,” says Eric K. Olson, Chairman and Chief Executive Officer of SINTX Technologies.
SINTX’s interest in 3D printing goes beyond polymers. In 2023, the company started working with 3DCERAM Sinto on a silicon nitride-based resin for ceramic 3D printing.
SINTX now has the facility, printers and a material supplier in place. FDA 510(k) clearance therefore remains a key milestone. It could help turn SiN/PEEK from a promising composite into a commercial implant material.
THE 3D ADEPT WEEKLY NEWSLETTER
The industry moves fast. Stay ahead.
Every week, the latest additive manufacturing news, in-depth features and real-world applications, straight to your inbox. Plus, be the first to know when a new issue of 3D ADEPT Mag is out.
Free · One email a week · Unsubscribe anytime
Clicking loads our email provider’s sign-up form, including its analytics and Google’s anti-bot protection. You’re only subscribed if you complete the sign-up. Read our privacy policy.





